| 产品描述: | AZD-3463是ALK/IGF1R抑制剂。产品介绍:AZD-3463 (ALK/IGF1R inhibitor) 是一种ALK/IGF1R 抑制剂,对 ALK 作用的 Ki 值为 0.75 nM。AZD-3463 可诱导神经母细胞瘤细胞凋亡 (apoptosis) 和自噬 (autophagy)。;AZD3463 is a novel orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency. |
| 体内研究: |
AZD3463 (15 mg/kg;腹腔注射;每天一次,持续 2 天) 在不同原位 NB 异种移植小鼠模型中抑制肿瘤生长。 |
| 参考文献: |
1. Yongfeng Wang, et al. Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis. Sci Rep. 2016; 6: 19423. 2. Sausan A. Moharram, et al. The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia. Blood Cancer J. 2019 Feb; 9(2): 5. 3. Ozates NP, et al. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer. Life Sci. 2021 Jan 1;264:118643. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.227 ml |
11.137 ml |
22.274 ml |
| 5 mM |
0.445 ml |
2.227 ml |
4.455 ml |
| 10 mM |
0.223 ml |
1.114 ml |
2.227 ml |
| 50 mM |
0.045 ml |
0.223 ml |
0.445 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |